Endocrine therapy of endometrial cancer
- 1 January 1998
- book chapter
- Published by Springer Nature
- Vol. 94, 89-106
- https://doi.org/10.1007/978-1-4615-6189-7_6
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Estrogen and progesterone receptor content of endometrial carcinomas: Comparison of total tissue versus cancer component analysisGynecologic Oncology, 1990
- Estrogen replacement therapy following treatment for stage I endometrial carcinomaGynecologic Oncology, 1990
- Estrogen and progestin receptor levels as prognosticators for survival in endometrial cancerGynecologic Oncology, 1988
- Endometrial carcinoma: Steroid receptors and response to medroxyprogesterone acetateGynecologic Oncology, 1985
- Radiosensitizing effect of medroxyprogesterone acetate on endometrial cancer cells in vitroCancer, 1984
- Tamoxifen as a possible chemotherapeutic agent in endometrial adenocarcinomaGynecologic Oncology, 1981
- Estradiol and progesterone receptors in normal and neoplastic endometrium: Correlations between receptors, histopathological examinations and clinical responses under progestin therapyInternational Journal of Cancer, 1979
- Tamoxifen (ICI 46,474) and the human carcinoma 8S oestrogen receptorPublished by Elsevier ,1975
- Adjuvant progestogen therapy in the primary definitive treatment of endometrial cancerGynecologic Oncology, 1974
- The use of megestrol acetate in the treatment of advanced malignant lesions of the endometriumGynecologic Oncology, 1973